EWING, NJ--(Marketwire - November 05, 2008) - DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced today that Christopher J. Schaber, PhD, President and Chief Executive Officer of DOR, will be making a corporate presentation at the Rodman & Renshaw 10th Annual Healthcare Conference at 12 p.m. on Monday, November 10th, 2008.
